[go: up one dir, main page]

IL84780A - Horse ypsilon-interferon,its preparation,dna sequences encoding it and host organisms containing such sequences - Google Patents

Horse ypsilon-interferon,its preparation,dna sequences encoding it and host organisms containing such sequences

Info

Publication number
IL84780A
IL84780A IL84780A IL8478087A IL84780A IL 84780 A IL84780 A IL 84780A IL 84780 A IL84780 A IL 84780A IL 8478087 A IL8478087 A IL 8478087A IL 84780 A IL84780 A IL 84780A
Authority
IL
Israel
Prior art keywords
preparation
sequences
interferon
host organisms
ypsilon
Prior art date
Application number
IL84780A
Other languages
English (en)
Other versions
IL84780A0 (en
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of IL84780A0 publication Critical patent/IL84780A0/xx
Publication of IL84780A publication Critical patent/IL84780A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/249Interferons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/555Interferons [IFN]
    • C07K14/57IFN-gamma
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IL84780A 1986-12-10 1987-12-10 Horse ypsilon-interferon,its preparation,dna sequences encoding it and host organisms containing such sequences IL84780A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863642096 DE3642096A1 (de) 1986-12-10 1986-12-10 Pferde-(gamma)-interferon

Publications (2)

Publication Number Publication Date
IL84780A0 IL84780A0 (en) 1988-05-31
IL84780A true IL84780A (en) 1992-11-15

Family

ID=6315829

Family Applications (1)

Application Number Title Priority Date Filing Date
IL84780A IL84780A (en) 1986-12-10 1987-12-10 Horse ypsilon-interferon,its preparation,dna sequences encoding it and host organisms containing such sequences

Country Status (20)

Country Link
US (1) US5602010A (hu)
EP (1) EP0271824B1 (hu)
JP (3) JPS63233794A (hu)
KR (1) KR880007568A (hu)
AT (1) ATE91722T1 (hu)
AU (1) AU616873B2 (hu)
CA (1) CA1339776C (hu)
DE (2) DE3642096A1 (hu)
DK (1) DK170054B1 (hu)
ES (1) ES2058094T3 (hu)
FI (1) FI99116C (hu)
HU (1) HU213566B (hu)
IE (1) IE60404B1 (hu)
IL (1) IL84780A (hu)
NO (1) NO180239C (hu)
NZ (1) NZ222856A (hu)
PH (1) PH30889A (hu)
PT (1) PT86332B (hu)
SU (1) SU1701114A3 (hu)
ZA (1) ZA879245B (hu)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO811118L (no) 1980-04-03 1981-10-05 Biogen Nv Dna-sekvenser, rekombinante dna-molekyler og fremgangsmaate ved fremstilling av polypeptider
US5272263A (en) * 1989-04-28 1993-12-21 Biogen, Inc. DNA sequences encoding vascular cell adhesion molecules (VCAMS)
US6307025B1 (en) 1989-04-28 2001-10-23 Biogen, Inc. VCAM fusion proteins and DNA coding therefor
US7049102B1 (en) 1989-09-22 2006-05-23 Board Of Trustees Of Leland Stanford University Multi-gene expression profile
GB9414752D0 (en) * 1994-07-21 1994-09-07 Q One Biotech Ltd Feline gamma-interferon
GB2291645A (en) * 1994-07-21 1996-01-31 Q One Biotech Ltd Equine gamma-interferon
JP4220235B2 (ja) * 2000-11-03 2009-02-04 インターシア セラピューティクス,インコーポレイティド 短期及び長期の薬剤薬量決定のための方法
EP1536839B1 (en) * 2001-11-09 2010-09-15 Intarcia Therapeutics, Inc Combination therapy comprising omega-interferon for treating infection with hepatitis c virus or yellow fever virus
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
DE602007009377D1 (de) 2006-05-30 2010-11-04 Intarcia Therapeutics Inc Zweiteiliger flussmodulator mit einem internen kanal für ein osmotisches ausgabesystem
EP2359808B1 (en) 2006-08-09 2013-05-22 Intarcia Therapeutics, Inc Osmotic delivery systems and piston assemblies
AU2008244523B2 (en) 2007-04-23 2012-02-16 Intarcia Therapeutics, Inc. Suspension formulations of insulinotropic peptides and uses thereof
DK2240155T3 (da) 2008-02-13 2012-09-17 Intarcia Therapeutics Inc Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler
LT2462246T (lt) 2009-09-28 2017-11-27 Intarcia Therapeutics, Inc Esminio stacionaraus vaisto tiekimo greitas įgyvendinimas ir (arba) nutraukimas
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
US10925639B2 (en) 2015-06-03 2021-02-23 Intarcia Therapeutics, Inc. Implant placement and removal systems
EP3458084B1 (en) 2016-05-16 2020-04-01 Intarcia Therapeutics, Inc Glucagon-receptor selective polypeptides and methods of use thereof
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
KR20190104039A (ko) 2017-01-03 2019-09-05 인타르시아 세라퓨틱스 인코포레이티드 Glp-1 수용체 효능제의 연속적인 투여 및 약물의 동시-투여를 포함하는 방법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE88622C (hu) *
ZA811368B (en) * 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
EP0088540A3 (en) * 1982-02-22 1984-10-17 Biogen, Inc. Dna sequences, recombinant dna molecules and processes for producing human immune interferon-like polypeptides
IE54592B1 (en) * 1982-03-08 1989-12-06 Genentech Inc Anumal interferons, processes involved in their production, compositions containing them, dna sequences coding therefor and espression vehicles containing such sequences and cells transformed thereby
DE3247922A1 (de) * 1982-12-24 1984-06-28 Boehringer Ingelheim International GmbH, 6507 Ingelheim Dna-sequenzen, deren herstellung, diese sequenzen enthaltende plasmide und deren verwendung zur synthese eukaryotischer genprodukte in prokaryoten
JPS60118196A (ja) * 1983-11-30 1985-06-25 Takeda Chem Ind Ltd インタ−フェロンの製造法
US4666865A (en) * 1984-01-13 1987-05-19 Centocor, Inc. Immunoassay for biologically active human interferon-gamma employing unique monoclonal antibodies
DE3414831A1 (de) * 1984-04-19 1985-10-31 Hoechst Ag, 6230 Frankfurt Herstellung von polypeptiden mit human-gammainterferon-aktivitaet
FI90990C (fi) * 1984-12-18 1994-04-25 Boehringer Ingelheim Int Rekombinantti-DNA-molekyyli, transformoitu isäntäorganismi ja menetelmä interferonin valmistamiseksi
US4689224A (en) * 1985-10-07 1987-08-25 Neogen Corporation Method for administering vaccines containing equine leukokines and compositions therefor
DE3607835A1 (de) * 1986-03-10 1987-09-24 Boehringer Ingelheim Int Hybridinterferone, deren verwendung als arzneimittel und als zwischenprodukte zur herstellung von antikoerpern und deren verwendung sowie verfahren zu ihrer herstellung
CA1340698C (en) * 1986-07-25 1999-08-10 Kabushiki Kaisha Hayashibara Seibutsu Kaguku Kenkyujo Preparation and uses of interferon-gamma
US4908432A (en) * 1987-01-09 1990-03-13 New York University Novel polypeptide having gamma-interferon activity

Also Published As

Publication number Publication date
JPS63233794A (ja) 1988-09-29
NO875136L (no) 1988-06-13
NO875136D0 (no) 1987-12-09
FI875427A (fi) 1988-06-11
KR880007568A (ko) 1988-08-27
DE3642096A1 (de) 1988-06-16
FI99116C (fi) 1997-10-10
DK645887D0 (da) 1987-12-09
IE873342L (en) 1988-06-10
DK645887A (da) 1988-06-11
AU616873B2 (en) 1991-11-14
AU8223387A (en) 1988-06-30
US5602010A (en) 1997-02-11
NO180239B (no) 1996-12-02
FI99116B (fi) 1997-06-30
DK170054B1 (da) 1995-05-08
PT86332A (de) 1988-01-01
CA1339776C (en) 1998-03-24
ZA879245B (en) 1989-08-30
ES2058094T3 (es) 1994-11-01
NO180239C (no) 1997-03-12
IL84780A0 (en) 1988-05-31
HU213566B (en) 1997-08-28
EP0271824A3 (en) 1989-05-24
PT86332B (pt) 1990-11-07
EP0271824A2 (de) 1988-06-22
NZ222856A (en) 1991-11-26
PH30889A (en) 1997-12-23
HUT46066A (en) 1988-09-28
DE3786649D1 (de) 1993-08-26
JPH07250690A (ja) 1995-10-03
FI875427A0 (fi) 1987-12-10
ATE91722T1 (de) 1993-08-15
SU1701114A3 (ru) 1991-12-23
JPH07258294A (ja) 1995-10-09
EP0271824B1 (de) 1993-07-21
IE60404B1 (en) 1994-07-13

Similar Documents

Publication Publication Date Title
IL84780A (en) Horse ypsilon-interferon,its preparation,dna sequences encoding it and host organisms containing such sequences
YU233582A (en) Process for the expression of a gene coded for human imunological interferon
DK491487D0 (da) Dna-sekvens til ekspressionering af biologisk aktivt faktor xiii og anvendelse af samme
CA2066370A1 (en) Yield when disulfide-bonded proteins are secreted
IL69469A (en) Polypeptide having human h1-relaxin activity,double-stranded dna fragments coding therefor,vectors containing the dna fragments and methods for preparing the polypeptide,dna fragments and vectors
IL92124A0 (en) Modified proteins,modified interferons,alpha and beta,phosphorylated proteins and analogues,dna sequences,applications and uses therefor
NO177570C (no) Fremgangsmåte ved fremstilling av peptider med fibronektinbindende egenskaper, mikroorganisme og DNA-sekvens som koder for peptider med fibronektinbindende egenskaper
ES8704207A1 (es) Procedimiento para preparar una molecula de adn
ES8107307A1 (es) Un procedimiento de preparacion de un vector de transferen- cia de adn
DE3881023D1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
GB8414354D0 (en) Purifying protein
EP0251244A3 (en) Polypeptide and production thereof
EP0427863A4 (en) Dna coding for protein capable of combining with enhancer of alpha-fetoprotein gene
PH20862A (en) Polypeptides and process for their preparation
EP0238275A3 (en) Recombinant product
IL78278A0 (en) Process for the production of polypeptides,dna sequence encoding desired polypeptide human somatomedin c polypeptide and recombinant dna molecules
EP0367641A3 (en) Lymphokines, dna sequences encoding these lymphokines and pharmaceutical compositions containing these lymphokines
IL81886A (en) Bacillus thuringiensis insecticidal proteinaceous substance,dna encoding it,its preparation and its use
NO178704C (no) DNA-sekvens som koder for protein med IRF-1-aktivitet, ekspresjonsvektor inneholdende denne, anvendelse av IRF-1 for å öke ekspresjon, vertscelle transformert med ekspresjonsvektoren, og protein med IRF-1-aktivitet

Legal Events

Date Code Title Description
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees